Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.55 |
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.54 |
| ▸ | HTR2C | P28335 | 1/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17026005 | 0.91 | DGKA (0.48) | DGKATSHRPRSS1PRSS2PRSS3 | |
| SCHEMBL15844796 | 0.91 | DGKA (0.48) | DGKATSHRPRSS1PRSS2PRSS3 | |
| SCHEMBL15844859 | 0.91 | DGKA (0.48) | DGKATSHRPRSS1PRSS2PRSS3 | |
| SCHEMBL15845090 | 0.91 | DGKA (0.48) | DGKATSHRPRSS1PRSS2PRSS3 | |
| SCHEMBL15844955 | 0.91 | DGKA (0.48) | DGKATSHRPRSS1PRSS2PRSS3 | |
| SCHEMBL15844908 | 0.91 | DGKA (0.48) | DGKATSHRPRSS1PRSS2PRSS3 | |
| SCHEMBL17026109 | 0.91 | DGKA (0.48) | DGKATSHRPRSS1PRSS2PRSS3 | |
| SCHEMBL15844902 | 0.91 | DGKA (0.48) | DGKATSHRPRSS1PRSS2PRSS3 | |
| SCHEMBL2994614 | 0.91 | DGKA (0.48) | DGKATSHRPRSS1PRSS2PRSS3 | |
| SCHEMBL15844825 | 0.91 | DGKA (0.48) | DGKATSHRPRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100242790-A1 | CATIONICALLY AND HYBRID CURABLE UV GELS | XEROX CORPORATION (US) | 2010-09-30 | — | — | US | claimed |
| EP-2233541-A1 | Cationically and hybrid curable UV gels | Xerox Corporation (US) | 2010-09-29 | — | — | EP | claimed |
| US-7326754-B2 | Thermoset adhesive films | HENKEL AG & CO. KGAA (DE) | 2008-02-05 | — | — | US | claimed |
| EP-1362901-B1 | Thermoset adhesive films | NAT STARCH CHEM INVEST (US) | 2006-03-15 | — | — | EP | claimed |
| US-20060030672-A1 | Thermoset adhesive films | HENKEL AG & CO. KGAA (DE) | 2006-02-09 | — | — | US | claimed |
| EP-1373339-B1 | SHAPE MEMORY STYRENE COPOLYMER | JOHNSON & JOHNSON VISION CARE (US) | 2006-01-18 | — | — | EP | claimed |
| EP-1373340-B1 | SHAPE MEMORY POLYMER OR ALLOY OPHTHALMIC LENS MOLD AND METHODS OF FORMING OPHTHALMIC PRODUCTS | JOHNSON & JOHNSON VISION CARE (US) | 2005-10-19 | — | — | EP | claimed |
| US-20050137340-A1 | Thermoset adhesive films | NIKOLIC NIKOLA A (US) | 2005-06-23 | — | — | US | claimed |
| US-6827325-B2 | Shape memory polymer or alloy ophthalmic lens mold and methods of forming ophthalmic products | JOHNSON & JOHNSON VISION CARE, INC. | 2004-12-07 | — | — | US | claimed |
| JP-2004521172-A | — | — | 2004-07-15 | — | — | JP | claimed |
| US-6759481-B2 | Shape memory styrene copolymer | CORNERSTONE RESEARCH GROUP, INC. | 2004-07-06 | — | — | US | claimed |
| EP-1373339-A1 | SHAPE MEMORY STYRENE COPOLYMER | Johnson & Johnson Vision Care, Inc. (US) | 2004-01-02 | — | — | EP | claimed |
| US-20030232926-A1 | Thermoset adhesive films | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2003-12-18 | — | — | US | claimed |
| EP-1362901-A2 | Thermoset adhesive films | National Starch and Chemical Investment Holding Corporation (US) | 2003-11-19 | — | — | EP | claimed |
| US-20020137864-A1 | Shape memory styrene copolymer | CORNERSTONE RESEARCH GROUP, INC. | 2002-09-26 | — | — | US | claimed |
| WO-2002059170-A1 | SHAPE MEMORY STYRENE COPOLYMER | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2002-08-01 | — | — | WO | claimed |
| EP-4565378-B1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2026-05-06 | — | — | EP | disclosed |
| US-12616995-B2 | Methods for producing overt security features exhibiting one or more indicia | SICPA HOLDING SA (CH) | 2026-05-05 | — | — | US | disclosed |
| WO-2002059169-A1 | SHAPE MEMORY POLYMER OR ALLOY OPHTHALMIC LENS MOLD AND METHODS OF FORMING OPHTHALMIC PRODUCTS | JOHNSON & JOHNSON VISION CARE , INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| WO-2002048457-A2 | SOFT TISSUE WITH IMPROVED LINT AND SLOUGH PROPERTIES | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616995-B2 | Methods for producing overt security features exhibiting one or more indicia | ATG4B, TPM4, ATG4A | DGKA 2233/4885TSHR 416/4885PRSS1 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.